Encuesta de recursos diagnósticos de las ITS en España / Survey of diagnostic resources for STI in Spain

Introducción: Hay escasa información sobre los recursos disponibles tanto en las consultas como en el laboratorio para hacer frente a las infecciones de transmisión sexual (ITS). El objetivo es describir y conocer la realidad de las consultas y laboratorios que atienden las ITS en España. Métodos: Estudio observacional transversal con obtención de datos mediante una encuesta dirigida a los miembros del Grupo de ITS de la SEIMC (GEITS). Resultados: Se obtuvieron respuestas de 24 centros (tasa de respuesta, 38,1%) pertenecientes a 10comunidades autónomas. Respecto a las consultas de ITS, el 38% precisan que el paciente presente tarjeta sanitaria para proporcionar asistencia, y un 31,8% solo la prestan mediante derivación de otro médico. El 52,4% realizan métodos diagnósticos en la propia consulta. El 18,2% de los laboratorios no ofrecen pruebas diagnósticas de respuesta inmediata, aunque el 100% disponen de PCR frente a Neisseria gonorrhoeae y Chlamydia trachomatis, el 47,8% frente a Mycoplasma genitalium y el 65% detectan genotipos del linfogranuloma venéreo. El 20% realizan técnicas de detección molecular de resistencias antimicrobianas. Todos los laboratorios realizan cultivo y técnicas de sensibilidad a gonococo. Conclusiones: Existe una gran variabilidad en las dotaciones de medios humanos y materiales en las consultas y en los laboratorios que atienden ITS. En un número importante de centros existen limitaciones para el acceso de los pacientes. Todos los laboratorios disponen de técnicas de biología molecular y detectan la infección de N.gonorrhoeae mediante PCR y cultivo, lo que permite la realización de pruebas de sensibilidad en todos los centros.(AU)

Background: Scarce information is available on the resources to deal with the Sexually Transmitted Infections (STIs), both in the clinic and in the laboratory. The objective is to describe and know the reality of the clinics and laboratories that treat these infections in Spain. Methods: Cross-sectional observational study with data collection through a survey aimed at the members of the GEITS Group. Results: Responses were obtained from 24 centers (response rate 38.1%) belonging to 10Autonomous Communities. Regarding STI consultations, 38% require that the patient present a health card to provide assistance, and 31.8% only provide it by referral from another doctor. The 52.4% perform diagnostic methods in the care center. Regarding laboratories, 18.2% do not offer immediate response diagnostic tests, although 100% have PCR against Neisseria gonorrhoeae and Chlamydia trachomatis, 47.8% against Mycoplasma genitalium and 65% detect lymphogranuloma venereum genotypes. All laboratories continue to perform culture and gonococcal sensitivity techniques, and 20% perform molecular methods for detection of MG antimicrobial resistance. Conclusion: There is great variability in the provision of human and material resources both in the clinics and in the laboratories that attend STIs. In a significant number of centers there are limitations for patient access. Although laboratories have molecular biology technologies, not all of them offer immediate response tests. All laboratories detect N.gonorrhoeae infection by PCR and also by culture, which allows sensitivity testing in all centers.(AU)

Survey of diagnostic resources for STI in Spain.

BACKGROUND: Scarce information is available on the resources to deal with the Sexually Transmitted Infections (STIs), both in the clinic and in the laboratory. The objective is to describe and know the reality of the clinics and laboratories that treat these infections in Spain. METHODS: Cross-sectional observational study with data collection through a survey aimed at the members of the GEITS Group. RESULTS: Responses were obtained from 24 centers (response rate 38.1%) belonging to 10 Autonomous Communities. Regarding STI consultations, 38% require that the patient present a health card to provide assistance, and 31.8% only provide it by referral from another doctor. The 52.4% perform diagnostic methods in the care center. Regarding laboratories, 18.2% do not offer immediate response diagnostic tests, although 100% have PCR against Neisseria gonorrhoeae and Chlamydia trachomatis, 47.8% against Mycoplasma genitalium and 65% detect lymphogranuloma venereum genotypes. All laboratories continue to perform culture and gonococcal sensitivity techniques, and 20% perform molecular methods for detection of MG antimicrobial resistance. CONCLUSION: There is great variability in the provision of human and material resources both in the clinics and in the laboratories that attend STIs. In a significant number of centers there are limitations for patient access. Although laboratories have molecular biology technologies, not all of them offer immediate response tests. All laboratories detect N. gonorrhoeae infection by PCR and also by culture, which allows sensitivity testing in all centers.

Survey of diagnostic resources for STI in Spain. / Encuesta de recursos diagnósticos de las ITS en España.

BACKGROUND: Scarce information is available on the resources to deal with the Sexually Transmitted Infections (STIs), both in the clinic and in the laboratory. The objective is to describe and know the reality of the clinics and laboratories that treat these infections in Spain. METHODS: Cross-sectional observational study with data collection through a survey aimed at the members of the GEITS Group. RESULTS: Responses were obtained from 24 centers (response rate 38.1%) belonging to 10Autonomous Communities. Regarding STI consultations, 38% require that the patient present a health card to provide assistance, and 31.8% only provide it by referral from another doctor. The 52.4% perform diagnostic methods in the care center. Regarding laboratories, 18.2% do not offer immediate response diagnostic tests, although 100% have PCR against Neisseria gonorrhoeae and Chlamydia trachomatis, 47.8% against Mycoplasma genitalium and 65% detect lymphogranuloma venereum genotypes. All laboratories continue to perform culture and gonococcal sensitivity techniques, and 20% perform molecular methods for detection of MG antimicrobial resistance. CONCLUSION: There is great variability in the provision of human and material resources both in the clinics and in the laboratories that attend STIs. In a significant number of centers there are limitations for patient access. Although laboratories have molecular biology technologies, not all of them offer immediate response tests. All laboratories detect N.gonorrhoeae infection by PCR and also by culture, which allows sensitivity testing in all centers.

Diagnóstico molecular de la sífilis / Molecular diagnostic of syphilis

La sífilis es una infección de transmisión sexual causada por Treponema pallidum subsp. pallidum, cuya incidencia está aumentando en España y en el resto del mundo. El diagnóstico se basa fundamentalmente en la serología, puesto que el diagnóstico directo mediante microscopía de campo oscuro presenta dificultades que limitan su generalización. Las técnicas de biología molecular pueden ser una herramienta útil para el diagnóstico en sífilis primaria y secundaria, si bien no todos los tipos de muestra se comportan igual. También son útiles para el diagnóstico de la sífilis congénita, mientras que para la neurosífilis, y debido a la baja sensibilidad de la reacción en cadena de la polimerasa en el líquido cefalorraquídeo, no se recomiendan. Estás técnicas se han empleado para estudiar el controvertido origen de la sífilis, y mediante el sistema mejorado de los Centers for Disease Control and Prevention para realizar la tipificación que ayude a comprender mejor la epidemiología. Por último, las técnicas moleculares permiten determinar la presencia de mutaciones relacionadas con resistencia a los macrólidos, presentes en un porcentaje muy elevado de las infecciones

Syphilis is a sexually transmitted infection caused by Treponema pallidum subsp. pallidum with an increasing incidence in Spain and in the rest of the world. Diagnosis is based mainly on serology, since direct diagnosis by dark field microscopy presents difficulties that limit its widespread use. Molecular biology techniques can be a useful tool for diagnosis in primary and secondary syphilis, although not all types of samples show the same behaviour. These techniques are also useful for the diagnosis of congenital syphilis. They are not recommended, however, for neurosyphilis, due to the low sensitivity of polymerase chain reaction in cerebrospinal fluid. These techniques have been used to study the controversial origin of syphilis, and, through the enhanced Centers for Disease Control method, to perform typing, which helps to elucidate the epidemiology of this infection. Finally, molecular techniques can detect mutations related to macrolide resistance, which are present in a very high percentage of infections

Sífilis / Syphilis

La sífilis está causada por la espiroqueta Treponema pallidum subsp. Pallidum, que se transmite por vía sexual o vertical durante la gestación. Su incidencia se ha incrementado en los últimos años, especialmente entre los hombres que tienen sexo con hombres. Sin tratamiento, la infección progresa en distintas fases que terminan en complicaciones irreversibles neurológicas y cardiovasculares. Para su clasificación diferenciamos entre sífilis precoz (primaria, secundaria y latente de menos de un año), que es infecciosa, de la sífilis tardía (latente de más de un año y terciaria), en la que el paciente no es contagioso. El diagnóstico y el tratamiento no es sencillo debido a la gran variedad de manifestaciones clínicas y a la dificultad en la interpretación de las pruebas serológicas. El tratamiento de la sífilis se basa en la administración de penicilina o de doxiciclina en casos de alergia. Con azitromicina se han descrito fracasos terapéuticos y se han encontrado resistencias. Los pacientes que hayan sido diagnosticados y tratados deben de ser seguidos para evaluar la respuesta al tratamiento y diagnosticar posibles reinfecciones

Syphilis is an infectious disease caused by the spirochaete Treponema pallidum subsp. pallidum which is transmitted by sexual contact or vertical transmission during pregnancy. The incidence of syphilis has increased in the last years, mainly among men who have sex with men. Without treatment, the disease develops into different clinical stages, being able to present cardiovascular or irreversible neurological complications after a number of years. The disease is classified as early syphilis - primary, secondary and early latent syphilis (less than 12 months) - which is contagious, and as late syphilis - late latent and tertiary syphilis- which is rarely contagious. Diagnosis and management are often a challenge because of its diversity of manifestations and the difficulty of interpretation of serological tests. The treatment of syphilis is based on penicillin or doxycycline in allergic patients. Treatment failure because of resistance has been described with azithromycin. The follow up with a serological test is recommended in all patients with syphilis in order to ascertain cure after the treatment and to diagnose possible reinfections

Syphilis. / Sífilis.

Syphilis is an infectious disease caused by the spirochaete Treponema pallidum subsp. pallidum which is transmitted by sexual contact or vertical transmission during pregnancy. The incidence of syphilis has increased in the last years, mainly among men who have sex with men. Without treatment, the disease develops into different clinical stages, being able to present cardiovascular or irreversible neurological complications after a number of years. The disease is classified as early syphilis - primary, secondary and early latent syphilis (less than 12 months) - which is contagious, and as late syphilis - late latent and tertiary syphilis- which is rarely contagious. Diagnosis and management are often a challenge because of its diversity of manifestations and the difficulty of interpretation of serological tests. The treatment of syphilis is based on penicillin or doxycycline in allergic patients. Treatment failure because of resistance has been described with azithromycin. The follow up with a serological test is recommended in all patients with syphilis in order to ascertain cure after the treatment and to diagnose possible reinfections.

Impacto de la resistencia microbiana en las decisiones terapéuticas de las infecciones de transmisión sexual / Impact of microbial resistance on therapeutic decisions in sexually transmitted infections

No disponible

Detección de infecciones de transmisión sexual por técnicas de biología molecular / Detection of sexually transmitted infections using molecular biology techniques

Las infecciones de transmisión sexual precisan para su control de pruebas diagnósticas rápidas, fiables y que permitan su realización en situaciones de cribado. Las técnicas de biología molecular han supuesto una verdadera revolución diagnóstica. Debido a su elevada sensibilidad, no solo detectan más infecciones, sino que permiten la obtención de muestras poco invasivas que facilitan los programas de cribado y evitan el rechazo de los pacientes a la realización de toma de muestras. La mejora de su especificidad evita en muchos casos la realización de pruebas de confirmación, bajo la premisa del cumplimiento de normas de calidad. También permiten diagnosticar patógenos que las técnicas de cultivo son incapaces de recuperar, y cada vez tenemos plataformas diagnósticas más sencillas, versátiles y en formato múltiple que agilizan el trabajo en el laboratorio e incluso fuera de él (AU)

Sexually transmitted infections (STI) require rapid, reliable diagnostic tests that can be performed in screening situations. Molecular biology techniques have been a true diagnostic revolution. Due to their high sensitivity, they detect more infections and allow non-invasive sample collection, simplifying screening programs and minimising patient refusal to have samples taken. Improvements in specificity have reduced the need for confirmation tests in many cases, under the premise of compliance with quality standards. They also allow to identify pathogens that culture techniques are unable to recover. Moreover, diagnostic platforms are increasingly simple, versatile and available in multiplex format, facilitating work inside and outside the laboratory (AU)

Diagnóstico rápido de las infecciones de transmisión sexual / Rapid diagnosis of sexually transmitted infections

Las infecciones de transmisión sexual (ITS) suponen una importante carga de morbimortalidad. A nivel mundial todos los años se producen millones de casos de ITS como sífilis, infección por clamidias o gonococia, y actualmente se asiste a un incremento de la resistencia a los antimicrobianos en patógenos como el gonococo. La demora en el diagnóstico es uno de los factores que justifica la dificultad para controlar estas infecciones. Las pruebas de diagnóstico rápido permiten instaurar el tratamiento etiológico en la primera consulta, lo que lleva a tratar a más pacientes, tanto sintomáticos como asintomáticos, de forma más efectiva, e interrumpir sin demoras la cadena epidemiológica de transmisión. La OMS incluye estas pruebas en su estrategia mundial contra las ITS (AU)

Sexually transmitted infections (STIs) are responsible for an enormous burden of morbidity and mortality. Worldwide, millions of cases of STIs, such as syphilis, chlamydia, or gonorrhoea occur every year, and there is now an increase in antimicrobial resistance in pathogens, such as gonococcus. Delay in diagnosis is one of the factors that justifies the difficulty in controlling these infections. Rapid diagnostic tests allow the introduction of aetiological treatment at the first visit, and also leads to treating symptomatic and asymptomatic patients more effectively, as well as to interrupt the epidemiological transmission chain without delay. The World Health Organisation includes these tests in its global strategy against STIs (AU)

Rapid diagnosis of sexually transmitted infections. / Diagnóstico rápido de las infecciones de transmisión sexual.

Sexually transmitted infections (STIs) are responsible for an enormous burden of morbidity and mortality. Worldwide, millions of cases of STIs, such as syphilis, chlamydia, or gonorrhoea occur every year, and there is now an increase in antimicrobial resistance in pathogens, such as gonococcus. Delay in diagnosis is one of the factors that justifies the difficulty in controlling these infections. Rapid diagnostic tests allow the introduction of aetiological treatment at the first visit, and also leads to treating symptomatic and asymptomatic patients more effectively, as well as to interrupt the epidemiological transmission chain without delay. The World Health Organisation includes these tests in its global strategy against STIs.

Prevalence of genital Chlamydia trachomatis infection among young men and women in Spain.

BACKGROUND: There are no accurate data regarding the real prevalence of Chlamydia trachomatis infection in Spain. Our aim was to determine the prevalence of C. trachomatis infections and the risk factors for acquiring them among 1,048 young (15-24 years old) inhabitants of Laviana. METHODS: The study was completed in the period between 1st November 2010 and 31st December 2011. We conducted a capture strategy in the whole population, instead of only in a sample group, with a capture conducted in schools, in the local health centre, by post and by phone as a last resort. The design was based on the model used by Shafer to increase screening rates. C. trachomatis was identified by RT-PCR in urine samples. RESULTS: A total of 487 sexually active people underwent the test, which implies a response rate of 59.8% of the sexually active people (target population). The prevalence was 4.1% (CI 95%: 3.1-5.8): women: 4% ( CI 95%; 2.8-6.4) and men: 4.3% (CI 95%: 2.9-7.2). The circulating genotype was the E genotype. There was an increase in the risk of C. trachomatis infection when barrier contraceptives were not routinely used OR: 4.76 (CI 95%:1.30-17.36) p<0.05. CONCLUSIONS: In our study the prevalence in women resembles those found in other countries in Europe and the prevalence in men is similar to that in women. Screening for C. trachomatis infection in women would be cost-effective in Spain given the prevalence of C. trachomatis measured by this study. The use of a condom is the best preventative measure for avoiding STIs in sexually active people.

[Update on the epidemiology, diagnosis and treatment of sexually-transmitted infections]. / Panorama actual de la epidemiología, diagnóstico y tratamiento de las infecciones de transmisión sexual.

In the last decade, cases of sexually-transmitted infections (STIs) have progressively increased in Europe. The reasons for this increase are unclear, but may involve changes in social behavior, migration and international travel, coupled with the emergence of risk groups that have not been taken into sufficient consideration to date. The routine use of molecular diagnostic techniques for many of these infections has solved many problems of sensitivity and the suitability of samples for microbiological diagnosis: non-invasive samples can be used, which has undoubtedly contributed to the increase in the number of cases. Moreover, molecular methods have also been introduced for antibiotic and antiviral susceptibility testing, as well as for molecular characterization of clinical isolates. All of these factors, together with the approval of the vaccine against the human papillomavirus, have changed the landscape of STIs across Europe.

Panorama actual de la epidemiología, diagnóstico y tratamiento de las infecciones de transmisión sexual / Update on the epidemiology, diagnosis and treatment of sexually-transmitted infections

En la última década se ha constatado un aumentoprogresivo de los casos de infecciones de transmisiónsexual en el territorio europeo. Las causas de esteaumento no están claras, pero parece influido por cambiosen las conductas sociales, los fenómenos migratorios y losviajes internacionales, junto con la aparición de grupos deriesgo no suficientemente valorados hasta ahora. Lautilización habitual de técnicas de diagnóstico molecularpara muchas de estas infecciones ha resuelto muchosproblemas de sensibilidad e idoneidad de las muestraspara el diagnóstico microbiológico, pudiéndose emplearmuestras no invasivas, y ha contribuido, sin duda, a esteaumento de casos. Por otro lado, los métodos molecularestambién se van implantando en el estudio de lasensibilidad a los antibióticos y antivirales, así como parala caracterización molecular de los aislados. Todo loanterior, junto a la aprobación de la vacuna frente al virusdel papiloma humano, ha cambiado el panorama de lasinfecciones de transmisión sexual en el territorio europeo(AU)

In the last decade, cases of sexually-transmitted infections(STIs) have progressively increased in Europe. The reasonsfor this increase are unclear, but may involve changes insocial behavior, migration and international travel, coupledwith the emergence of risk groups that have not beentaken into sufficient consideration to date.The routine use of molecular diagnostic techniques formany of these infections has solved many problems of sensitivity and the suitability of samples formicrobiological diagnosis: non-invasive samples can beused, which has undoubtedly contributed to the increasein the number of cases. Moreover, molecular methodshave also been introduced for antibiotic and antiviralsusceptibility testing, as well as for molecularcharacterization of clinical isolates. All of these factors,together with the approval of the vaccine against thehuman papillomavirus, have changed the landscape ofSTIs across Europe(AU)

Panorama actual de la epidemiología, diagnóstico y tratamiento de las infecciones de transmisión sexual / Update on the epidemiology, diagnosis and treatment of sexually-transmitted infections

En la última década se ha constatado un aumentoprogresivo de los casos de infecciones de transmisiónsexual en el territorio europeo. Las causas de esteaumento no están claras, pero parece influido por cambiosen las conductas sociales, los fenómenos migratorios y los viajes internacionales, junto con la aparición de grupos de riesgo no suficientemente valorados hasta ahora. La utilización habitual de técnicas de diagnóstico molecular para muchas de estas infecciones ha resuelto muchos problemas de sensibilidad e idoneidad de las muestras para el diagnóstico microbiológico, pudiéndose emplear muestras no invasivas, y ha contribuido, sin duda, a este aumento de casos. Por otro lado, los métodos moleculares también se van implantando en el estudio de la sensibilidad a los antibióticos y antivirales, así como para la caracterización molecular de los aislados. Todo lo anterior, junto a la aprobación de la vacuna frente al virus del papiloma humano, ha cambiado el panorama de las infecciones de transmisión sexual en el territorio europeo

In the last decade, cases of sexually-transmitted infections (STIs) have progressively increased in Europe. The reasons for this increase are unclear, but may involve changes in social behavior, migration and international travel, coupled with the emergence of risk groups that have not been taken into sufficient consideration to date.The routine use of molecular diagnostic techniques formany of these infections has solved many problems ofsensitivity and the suitability of samples formicrobiological diagnosis: non-invasive samples can beused, which has undoubtedly contributed to the increasein the number of cases. Moreover, molecular methodshave also been introduced for antibiotic and antiviralsusceptibility testing, as well as for molecularcharacterization of clinical isolates. All of these factors, together with the approval of the vaccine against the human papillomavirus, have changed the landscape of STIs across Europe

Utilidad de las técnicas de biología molecular en el diagnóstico de las infecciones de transmisión sexual y otras infecciones genitales / Utility of molecular biology techniques in the diagnosis of sexually transmitted diseases and genital infections

Históricamente, el diagnóstico de las infecciones de transmisión sexual ha sido difícil. La introducción en el diagnóstico microbiológico de las técnicas de biología molecular y su aplicación a muestras no invasivas ha permitido importantes avances en su diagnóstico. En general, la detección de Neisseria gonorrhoeae mediante técnicas de biología molecular proporciona un diagnóstico presuntivo y requiere confirmación por cultivo en zonas de baja prevalencia. Para Chlamydia trachomatis, estas técnicas se consideran como las más sensibles y específicas, tanto para estudios de cribado poblacional, como para el diagnóstico de pacientes sintomáticos. El diagnóstico de Mycoplasma genitalium por cultivo es muy lento, por ello, las técnicas moleculares son las únicas que pueden aportar información diagnóstica relevante. Para Treponema pallidum, las técnicas moleculares pueden aportar ventajas en el diagnóstico directo de la infección. Respecto a la donovaniosis, las técnicas moleculares no están establecidas para el diagnóstico sistemático, aunque se recomiendan en manos expertas. En el caso de Haemophilus ducreyi, las dificultades del cultivo y su baja sensibilidad aconsejan el uso de métodos moleculares. En el herpes genital, las técnicas moleculares han comenzado a recomendarse para el diagnóstico sistemático y pueden convertirse en la técnica de referencia en poco tiempo. Para otras infecciones genitales, como vaginosis bacteriana, vulvovaginitis candidiásica y tricomoniasis, los métodos moleculares para el diagnóstico están poco establecidos. Respecto a las verrugas genitales, las técnicas de cribado y genotipado disponibles para muestras endocervicales podrían utilizarse para ciertas poblaciones, aunque no se han validado para este cometido(AU)

Historically, the diagnosis of sexually transmitted diseases (STDs) has been difficult. The introduction of molecular biology techniques in microbiological diagnosis and their application to non-invasive samples has produced significant advances in the diagnosis of these diseases. Overall, detection of Neisseria gonorrhoeae by molecular biology techniques provides a presumptive diagnosis and requires confirmation by culture in areas with a low prevalence. For Chlamydia trachomatis infections, these techniques are considered to be the most sensitive and specific procedures for mass screening studies, as well as for the diagnosis of symptomatic patients. Diagnosis of Mycoplasma genitalium infection by culture is very slow and consequently molecular techniques are the only procedures that can provide relevant diagnostic information. For Treponema pallidum, molecular techniques can provide direct benefits in the diagnosis of infection. Molecular techniques are not established for the routine diagnosis of donovanosis, but can be recommended when performed by experts. Molecular methods are advisable in Haemophilus ducreyi, because of the difficulties of culture and its low sensitivity. In genital herpes, molecular techniques have begun to be recommended for routine diagnosis and could soon become the technique of choice. For other genital infections, bacterial vaginosis, vulvovaginal candidosis and trichomoniasis, diagnosis by molecular methods is poorly established. With genital warts, techniques available for screening and genotyping of endocervical samples could be used for certain populations, but are not validated for this purpose(AU)

Utilidad de las técnicas de biología molecular en el diagnóstico de las infecciones de transmisión sexual y otras infecciones genitales / Utility of molecular biology techniques in the diagnosis of sexually transmitted diseases and genital infections

Históricamente, el diagnóstico de las infecciones detransmisión sexual ha sido difícil. La introducción en eldiagnóstico microbiológico de las técnicas de biologíamolecular y su aplicación a muestras no invasivas hapermitido importantes avances en su diagnóstico. Engeneral, la detección de Neisseria gonorrhoeae mediantetécnicas de biología molecular proporciona un diagnósticopresuntivo y requiere confirmación por cultivo en zonas de baja prevalencia. Para Chlamydia trachomatis, estastécnicas se consideran como las más sensibles yespecíficas, tanto para estudios de cribado poblacional,como para el diagnóstico de pacientes sintomáticos. Eldiagnóstico de Mycoplasma genitalium por cultivo es muylento, por ello, las técnicas moleculares son las únicas que pueden aportar información diagnóstica relevante. Para Treponema pallidum, las técnicas moleculares puedenaportar ventajas en el diagnóstico directo de la infección. Respecto a la donovaniosis, las técnicas moleculares no están establecidas para el diagnóstico sistemático, aunque se recomiendan en manos expertas. En el caso de Haemophilus ducreyi, las dificultades del cultivo y su baja sensibilidad aconsejan el uso de métodos moleculares. En el herpes genital, las técnicas moleculares han comenzado a recomendarse para el diagnóstico sistemático y pueden convertirse en la técnica de referencia en poco tiempo. Para otras infecciones genitales, como vaginosis bacteriana, vulvovaginitis candidiásica y tricomoniasis, losmétodos moleculares para el diagnóstico están pocoestablecidos. Respecto a las verrugas genitales, lastécnicas de cribado y genotipado disponibles paramuestras endocervicales podrían utilizarse para ciertaspoblaciones, aunque no se han validado para estecometido

Historically, the diagnosis of sexually transmitted diseases (STDs) has been difficult. The introduction of molecular biology techniques in microbiological diagnosis and their application to non-invasive samples has produced significant advances in the diagnosis of these diseases. Overall, detection of Neisseria gonorrhoeae by molecular biology techniques provides a presumptive diagnosis and requires confirmation by culture in areas with a low prevalence. For Chlamydia trachomatis infections, these techniques are considered to be the most sensitive and specific procedures for mass screening studies, as well as for the diagnosis of symptomatic patients. Diagnosis of Mycoplasma genitalium infection by culture is very slow and consequently molecular techniques are the only procedures that can provide relevant diagnostic information. For Treponema pallidum, molecular techniques can provide direct benefits in the diagnosis of infection. Molecular techniques are not established for the routine diagnosis of donovanosis, but can be recommended when performed by experts. Molecular methods are advisable in Haemophilus ducreyi, because of the difficulties of culture and its low sensitivity. In genital herpes, molecular techniques have begun to be recommended for routine diagnosis and could soon become the technique of choice. For other genital infections, bacterial vaginosis, vulvovaginal candidosis and trichomoniasis, diagnosis by molecular methods is poorly established. With genital warts, techniques available for screening and genotyping of endocervical samples could be used for certain populations, but are not validated for this purpose

[Utility of molecular biology techniques in the diagnosis of sexually transmitted diseases and genital infections]. / Utilidad de las técnicas de biología molecular en el diagnóstico de las infecciones de transmisión sexual y otras infecciones genitales.

Historically, the diagnosis of sexually transmitted diseases (STDs) has been difficult. The introduction of molecular biology techniques in microbiological diagnosis and their application to non-invasive samples has produced significant advances in the diagnosis of these diseases. Overall, detection of Neisseria gonorrhoeae by molecular biology techniques provides a presumptive diagnosis and requires confirmation by culture in areas with a low prevalence. For Chlamydia trachomatis infections, these techniques are considered to be the most sensitive and specific procedures for mass screening studies, as well as for the diagnosis of symptomatic patients. Diagnosis of Mycoplasma genitalium infection by culture is very slow and consequently molecular techniques are the only procedures that can provide relevant diagnostic information. For Treponema pallidum, molecular techniques can provide direct benefits in the diagnosis of infection. Molecular techniques are not established for the routine diagnosis of donovanosis, but can be recommended when performed by experts. Molecular methods are advisable in Haemophilus ducreyi, because of the difficulties of culture and its low sensitivity. In genital herpes, molecular techniques have begun to be recommended for routine diagnosis and could soon become the technique of choice. For other genital infections, bacterial vaginosis, vulvovaginal candidosis and trichomoniasis, diagnosis by molecular methods is poorly established. With genital warts, techniques available for screening and genotyping of endocervical samples could be used for certain populations, but are not validated for this purpose.